Prospectus: information for the user
Paracetamol
Read the entire prospectus carefully before starting to use this medication, as it contains important information for you. Follow the administration instructions of the medication contained in this prospectus or as indicated by your pharmacist.
|
Contents of the prospectus:
Paracetamol is effective in reducing pain and fever.
It is indicated for the symptomatic relief of occasional mild or moderate pain, such as headache, dental, muscle (cramps) and fever.
Pediatric Gelocatil is indicated in children between 19 and 24 kg (from 5 to 7 years old).
Do not takePediatric Gelocatil
Be careful with Pediatric Gelocatil
If you have severe diseases, such as severe renal failure or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you suffer from malnutrition, chronic alcoholism, or if you are also taking flucloxacillin (an antibiotic). A severe disease called metabolic acidosis (an anomaly in blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling of discomfort (nausea) and vomiting.
Using Pediatric Gelocatil with other medications
Tell your doctor or pharmacist if you are using or have recently used any other medication, including those purchased without a prescription.
In particular, if you are using medications that contain any of the following active ingredients, as it may be necessary to reduce the dose of some of them or interrupt treatment:
Interference with analytical tests:
If you are going to have any analytical test (including blood, urine, etc.), tell your doctor that you are taking this medication, as it may alter the result of these tests.
Taking Pediatric Gelocatil with food and drinks
Taking this medication with food does not affect its efficacy.
Pregnancy
Consult your doctor or pharmacist before using any medication.
If necessary, Pediatric Gelocatil can be used during pregnancy. You should use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor if the pain or fever does not decrease or if you need to take the medication more frequently.
Breastfeeding
Consult your doctor or pharmacist before using any medication.
Paracetamol is excreted in breast milk, so breastfeeding women should consult their doctor or pharmacist before using this medication.
Children
Do not use in children with a weight of less than 19 kg (less than 5 years old) because it does not allow dosing of doses less than 1 sachet per intake (250 mg).
Driving and using machines
The influence of paracetamol on the ability to drive and use machines is null or insignificant.
Pediatric Gelocatil contains aspartame, sodium, sucrose, and glucose:
Aspartame contains a source of phenylalanine that can be harmful in case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it correctly.
.
Follow the administration instructions of the medication contained in this prospectus or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
It is necessary to respect the posologies defined according to the child's weight, and therefore, choose the appropriate dosage. The approximate age based on weight is given for informational purposes.
The recommended daily dose of paracetamol is approximately 60 mg/kg/day, which is divided into 4 or 6 daily doses, i.e., 15 mg/kg every 6 hours or 10 mg/kg every 4 hours.
Patients with liver or kidney disease: should consult their doctor before taking this medication. If your doctor prescribes this medication, you should wait at least 8 hours between two doses.
Pediatric Gelocatil is taken orally.
Open the sachet and pour the contents directly into the mouth. The granule disperses immediately in saliva and then swallows.
It can be taken with or without food.
Always use the lowest effective dose.
High daily doses of paracetamol should be avoided during prolonged periods, as the risk of adverse effects such as liver damage increases.
The administration of this medication is subject to the appearance of pain or fever. As they disappear, this medication should be discontinued.
If the pain or fever persists for more than 3 days or worsens, or if other symptoms appear, you should interrupt treatment and consult your doctor.
If the child takes more Pediatric Gelocatil than they should
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service (telephone 91 562 04 20, indicating the medication and the amount ingested)
If an overdose has been ingested, go quickly to a medical center, even if there are no symptoms, as they often do not manifest until 3 days after ingestion, even in cases of severe poisoning.
The symptoms of overdose may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), abdominal pain, and pancreatitis (inflammation of the pancreas).
Treatment of overdose is more effective if started within 4 hours of ingestion of the medication.
Patients treated with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
If you forgot to take Pediatric Gelocatil
Do not give the child a double dose to make up for the forgotten dose, simply give the forgotten dose when you remember, taking the following doses with the indicated separation in each case (4-6 hours).
Like all medications, Pediatric Gelocatil can have adverse effects, although not all people experience them.
Paracetamol can damage the liver when taken in high doses or in prolonged treatments.
Adverse effects of unknown frequency (cannot be estimated from available data): a severe disease that can make the blood more acidic (called metabolic acidosis) in patients with severe disease using paracetamol (see section 2).
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away in drains or trash. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Pediatric Gelocatil
The active ingredient is paracetamol. Each sachet contains 250 mg of paracetamol.
The other components (excipients) are calcium carbonate, sodium hydrogen carbonate, anhydrous citric acid, anhydrous sodium citrate, aspartame (E-951), mask it (composed of natural flavorings, natural identical flavorings, maltodextrin(contains glucose), sucrose, aspartame (E-951), and potassium acesulfame (E-950)), mannitol (E-421), lemon flavor, amorphous silica, glycerol (E-422) diester type 1, sodium croscarmellose, sodium carboxymethyl starch (type A potato starch), ethylcellulose, hydroxypropyl methylcellulose, polyethylene glycol 400.
Appearance of the product and package size
Pediatric Gelocatil is a white granule with a lemon odor, presented in sachets for oral administration.
Packaged in a box of 12 and 20 sachets.
Marketing authorization holder and manufacturer
Holder
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Manufacturer
Farmalider, S.A.
C/Aragoneses, 2
28108 Madrid
or
Biofabri, S.L.
A relva, S/n,
O Porriño
36400 Pontevedra
or
Edefarm, S.L
Polígono Industrial Enchilagar del Rullo, 117
46191 Villamarchante,
Valencia
Date of the last revision of this prospectus:February 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/